These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 27494686

  • 1. Lipoxin A4 protects against lipopolysaccharide-induced sepsis by promoting innate response activator B cells generation.
    Cheng Q, Wang Z, Ma R, Chen Y, Yan Y, Miao S, Jiao J, Cheng X, Kong L, Ye D.
    Int Immunopharmacol; 2016 Oct; 39():229-235. PubMed ID: 27494686
    [Abstract] [Full Text] [Related]

  • 2. Dual role of lipoxin A4 in pneumosepsis pathogenesis.
    Sordi R, Menezes-de-Lima O, Horewicz V, Scheschowitsch K, Santos LF, Assreuy J.
    Int Immunopharmacol; 2013 Oct; 17(2):283-92. PubMed ID: 23816538
    [Abstract] [Full Text] [Related]

  • 3. Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis.
    Walker J, Dichter E, Lacorte G, Kerner D, Spur B, Rodriguez A, Yin K.
    Shock; 2011 Oct; 36(4):410-6. PubMed ID: 21701419
    [Abstract] [Full Text] [Related]

  • 4. Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.
    Moreno C, Prieto P, Macías Á, Pimentel-Santillana M, de la Cruz A, Través PG, Boscá L, Valenzuela C.
    J Immunol; 2013 Dec 15; 191(12):6136-46. PubMed ID: 24249731
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Time-Dependent Protective and Pro-Resolving Effects of FPR2 Agonists on Lipopolysaccharide-Exposed Microglia Cells Involve Inhibition of NF-κB and MAPKs Pathways.
    Tylek K, Trojan E, Leśkiewicz M, Regulska M, Bryniarska N, Curzytek K, Lacivita E, Leopoldo M, Basta-Kaim A.
    Cells; 2021 Sep 09; 10(9):. PubMed ID: 34572022
    [Abstract] [Full Text] [Related]

  • 7. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation.
    Kure I, Nishiumi S, Nishitani Y, Tanoue T, Ishida T, Mizuno M, Fujita T, Kutsumi H, Arita M, Azuma T, Yoshida M.
    J Pharmacol Exp Ther; 2010 Feb 09; 332(2):541-8. PubMed ID: 19846590
    [Abstract] [Full Text] [Related]

  • 8. Regulation of aquaporin 4 expression by lipoxin A4 in astrocytes stimulated by lipopolysaccharide.
    Wu J, Ding D, Wang X, Li Q, Sun Y, Li L, Wang Y.
    Cell Immunol; 2019 Oct 09; 344():103959. PubMed ID: 31383359
    [Abstract] [Full Text] [Related]

  • 9. Lipoxin A(4) promotes more complete inflammation resolution in sepsis compared to stable lipoxin A(4) analog.
    Wu B, Walker JA, Temmermand D, Mian K, Spur B, Rodriguez A, Stein TP, Banerjee P, Yin K.
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jul 09; 89(1):47-53. PubMed ID: 23688707
    [Abstract] [Full Text] [Related]

  • 10. Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells.
    Marginean A, Sharma-Walia N.
    Transl Res; 2015 Aug 09; 166(2):111-33. PubMed ID: 25814167
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lipid mediator lipoxin A4 inhibits tumor growth by targeting IL-10-producing regulatory B (Breg) cells.
    Wang Z, Cheng Q, Tang K, Sun Y, Zhang K, Zhang Y, Luo S, Zhang H, Ye D, Huang B.
    Cancer Lett; 2015 Aug 10; 364(2):118-24. PubMed ID: 25979229
    [Abstract] [Full Text] [Related]

  • 13. Preeclampsia is associated with a deficiency of lipoxin A4, an endogenous anti-inflammatory mediator.
    Xu Z, Zhao F, Lin F, Xiang H, Wang N, Ye D, Huang Y.
    Fertil Steril; 2014 Jul 10; 102(1):282-290.e4. PubMed ID: 24796762
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis*.
    Ueda T, Fukunaga K, Seki H, Miyata J, Arita M, Miyasho T, Obata T, Asano K, Betsuyaku T, Takeda J.
    Crit Care Med; 2014 Apr 10; 42(4):e288-95. PubMed ID: 24463858
    [Abstract] [Full Text] [Related]

  • 15. Lipoxin A4 Attenuates the Inflammatory Response in Stem Cells of the Apical Papilla via ALX/FPR2.
    Gaudin A, Tolar M, Peters OA.
    Sci Rep; 2018 Jun 11; 8(1):8921. PubMed ID: 29892010
    [Abstract] [Full Text] [Related]

  • 16. Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.
    Colby JK, Gott KM, Wilder JA, Levy BD.
    Am J Respir Cell Mol Biol; 2016 Jan 11; 54(1):25-33. PubMed ID: 26039320
    [Abstract] [Full Text] [Related]

  • 17. Anti-Inflammatory Effects of OxPAPC Involve Endothelial Cell-Mediated Generation of LXA4.
    Ke Y, Zebda N, Oskolkova O, Afonyushkin T, Berdyshev E, Tian Y, Meng F, Sarich N, Bochkov VN, Wang JM, Birukova AA, Birukov KG.
    Circ Res; 2017 Jul 21; 121(3):244-257. PubMed ID: 28522438
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo.
    Sato Y, Kitasato H, Murakami Y, Hashimoto A, Endo H, Kondo H, Inoue M, Hayashi I.
    Biomed Pharmacother; 2004 Jul 21; 58(6-7):381-7. PubMed ID: 15271420
    [Abstract] [Full Text] [Related]

  • 19. Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury.
    Lv W, Lv C, Yu S, Yang Y, Kong H, Xie J, Sun H, Andersson R, Xu D, Chen B, Zhou M.
    Exp Biol Med (Maywood); 2013 Dec 21; 238(12):1388-95. PubMed ID: 24000382
    [Abstract] [Full Text] [Related]

  • 20. Effects of Lipoxin A4 on antimicrobial actions of neutrophils in sepsis.
    Wu B, Walker J, Spur B, Rodriguez A, Yin K.
    Prostaglandins Leukot Essent Fatty Acids; 2015 Mar 21; 94():55-64. PubMed ID: 25476955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.